178 related articles for article (PubMed ID: 6436447)
1. Comparison of various methods for delivering radiolabeled monoclonal antibody to normal rat brain.
Bullard DE; Bourdon M; Bigner DD
J Neurosurg; 1984 Nov; 61(5):901-11. PubMed ID: 6436447
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier disruption in immature Fischer 344 rats.
Bullard DE; Bigner DD
J Neurosurg; 1984 Apr; 60(4):743-50. PubMed ID: 6423781
[TBL] [Abstract][Full Text] [Related]
3. The effects of pentobarbital on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Chun TW; Liu X; Weiss HR
Anesth Analg; 1998 Jun; 86(6):1230-5. PubMed ID: 9620510
[TBL] [Abstract][Full Text] [Related]
4. Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits.
Wang M; Etu J; Joshi S
J Neurosurg Anesthesiol; 2007 Oct; 19(4):249-56. PubMed ID: 17893577
[TBL] [Abstract][Full Text] [Related]
5. Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption.
Yang W; Barth RF; Carpenter DE; Moeschberger ML; Goodman JH
Neurosurgery; 1996 May; 38(5):985-92. PubMed ID: 8727825
[TBL] [Abstract][Full Text] [Related]
6. Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood-brain barrier disruption: quantitative iodine biodistribution studies and associated dosimetry.
Adam JF; Biston MC; Joubert A; Charvet AM; Le Bas JF; Estève F; Elleaume H
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1173-82. PubMed ID: 15752899
[TBL] [Abstract][Full Text] [Related]
7. Effects of VEGF on the blood-brain barrier disruption caused by hyperosmolarity.
Chi OZ; Hunter C; Liu X; Tan T; Weiss HR
Pharmacology; 2008; 82(3):187-92. PubMed ID: 18708733
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
[TBL] [Abstract][Full Text] [Related]
9. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Kaya M; Gulturk S; Elmas I; Kalayci R; Arican N; Kocyildiz ZC; Kucuk M; Yorulmaz H; Sivas A
Life Sci; 2004 Nov; 76(2):201-12. PubMed ID: 15519365
[TBL] [Abstract][Full Text] [Related]
10. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
Hiesiger EM; Voorhies RM; Basler GA; Lipschutz LE; Posner JB; Shapiro WR
Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyethyl starch solution attenuates blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Lu X; Wei HM; Williams JA; Weiss HR
Anesth Analg; 1996 Aug; 83(2):336-41. PubMed ID: 8694315
[TBL] [Abstract][Full Text] [Related]
12. [The effect on the tumor vessel permeability by hyperosmotic blood brain barrier disruption].
Miyagami M; Tazoe M; Kagawa Y; Tsubokawa T
No To Shinkei; 1988 Sep; 40(9):875-82. PubMed ID: 3142506
[TBL] [Abstract][Full Text] [Related]
13. Effects of intracarotid hyperosmolar mannitol in triethyl tin (TET)-induced rat brain edema--preservation of blood-brain barrier (BBB) in TET edema.
Inoue T; Nagara H; Kondo A; Fukui M; Tateishi J
Brain Res; 1987 Jun; 414(2):309-13. PubMed ID: 3113663
[TBL] [Abstract][Full Text] [Related]
14. Hyperosmolar blood-brain barrier disruption in baboons: an in vivo study using positron emission tomography and rubidium-82.
Zünkeler B; Carson RE; Olson J; Blasberg RG; Girton M; Bacher J; Herscovitch P; Oldfield EH
J Neurosurg; 1996 Mar; 84(3):494-502. PubMed ID: 8609564
[TBL] [Abstract][Full Text] [Related]
15. Osmotic blood-brain barrier opening to IgM monoclonal antibody in the rat.
Neuwelt EA; Minna J; Frenkel E; Barnett PA; McCormick CI
Am J Physiol; 1986 May; 250(5 Pt 2):R875-83. PubMed ID: 3706572
[TBL] [Abstract][Full Text] [Related]
16. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
17. Onchocerca volvulus: characterization of monoclonal antibodies reactive with surface components of third-stage larvae.
Miller KM; Lustigman S; Brotman B; Andrus L; Weiss N; Hotze C; Prince AM
Trop Med Parasitol; 1991 Jun; 42(2):85-90. PubMed ID: 1896779
[TBL] [Abstract][Full Text] [Related]
18. Intravenous mannitol does not increase blood-brain barrier permeability to inert dyes in the adult rat forebrain.
Chen KB; Wei VC; Yen LF; Poon KS; Liu YC; Cheng KS; Chang CS; Lai TW
Neuroreport; 2013 Apr; 24(6):303-7. PubMed ID: 23426109
[TBL] [Abstract][Full Text] [Related]
19. The effects of morphine on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Lee DI; Liu X; Weiss HR
Anesth Analg; 2000 Mar; 90(3):603-8. PubMed ID: 10702444
[TBL] [Abstract][Full Text] [Related]
20. Increased blood-brain permeability with hyperosmolar mannitol increases cerebral O2 consumption and O2 supply/consumption heterogeneity.
Chi OZ; Wei HM; Lu X; Weiss HR
J Cereb Blood Flow Metab; 1996 Mar; 16(2):327-33. PubMed ID: 8594066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
